Suppr超能文献

山茱萸苷对人肝脏细胞色素P450酶的抑制作用。

Inhibitory effects of cornuside on human liver cytochrome P450 enzymes.

作者信息

Yang Yanmo, Zhang Ke, Zhou Mi

机构信息

Department of Pharmacy, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), No. 388, Renmin Road, Wuling District, Changde City, 415000, Hunan Province, China.

Department of Science and Education, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, 415000, China.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 13. doi: 10.1007/s00210-025-03856-y.

Abstract

Cornuside is an iridoid glycoside isolated from the fruits of Cornus officinalis Sieb. et Zucc. with antiallergic and hypoglycemic properties. This study aimed to investigate the interaction of cornuside with cytochrome P450 (CYP) enzymes which may provide a reference for the clinical application of Cornus officinalis. The impact of cornuside on CYP enzyme activity in human liver microsomes (HLMs) was examined in the presence of 0, 2.5, 5, 10, 25, 50, and 100 µM of cornuside. In order to estimate the inhibition properties, Lineweaver-Burk plots were plotted and kinetic parameters were obtained. Furthermore, the time-dependent inhibition of CYP3A4 activity by cornuside was also assessed. The activity of CYP3A4, 2C19, and 2E1 was suppressed by cornuside, with half-maximal inhibitory concentration (IC) values of 13.80, 19.44, and 24.55 µM, respectively. Furthermore, the inhibitory effect of cornuside was found to be non-competitive (K = 7.13 µM) and time-dependent (K = 7.19 µM, K = 0.042 min), whereas the inhibitory effect on CYP2C19 and 2E1 was found to be competitive, with K values of 9.92 µM and 12.38 µM, respectively. In vitro studies revealed that cornuside inhibited CYP3A4, 2C19, and 2E1. This indicates the possibility of drug-drug interaction between cornuside and drugs that are metabolized by these CYP enzymes when co-administered. These findings may provide a theoretical basis for clinical prescribing, particularly in the context of co-administration.

摘要

山茱萸苷是从山茱萸果实中分离出的一种环烯醚萜苷,具有抗过敏和降血糖特性。本研究旨在探讨山茱萸苷与细胞色素P450(CYP)酶的相互作用,可为山茱萸的临床应用提供参考。在存在0、2.5、5、10、25、50和100 μM山茱萸苷的情况下,检测了山茱萸苷对人肝微粒体(HLM)中CYP酶活性的影响。为了评估抑制特性,绘制了Lineweaver-Burk图并获得了动力学参数。此外,还评估了山茱萸苷对CYP3A4活性的时间依赖性抑制作用。山茱萸苷抑制了CYP3A4、2C19和2E1的活性,其半数最大抑制浓度(IC)值分别为13.80、19.44和24.55 μM。此外,发现山茱萸苷的抑制作用为非竞争性(K = 7.13 μM)和时间依赖性(K = 7.19 μM,K = 0.042 min),而对CYP2C19和2E1的抑制作用为竞争性,K值分别为9.92 μM和12.38 μM。体外研究表明,山茱萸苷抑制CYP3A4、2C19和2E1。这表明山茱萸苷与这些CYP酶代谢的药物合用时可能存在药物相互作用。这些发现可能为临床处方提供理论依据,特别是在联合用药的情况下。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验